1 / 39

Therapeutic Hypothermia Protocol for Brain Injuries

Therapeutic Hypothermia Protocol for Brain Injuries. Paige Whitmire Dietetic Intern 2014-2015. Background Information. “Old” practice ideas to reduce ICP Fluid restriction Use of Mannitol (diuretic) Hyperventilate (decrease CO2 levels) No feeding due to glucose metabolism risk

bergerc
Download Presentation

Therapeutic Hypothermia Protocol for Brain Injuries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Therapeutic Hypothermia Protocol for Brain Injuries Paige Whitmire Dietetic Intern 2014-2015

  2. Background Information • “Old” practice ideas to reduce ICP • Fluid restriction • Use of Mannitol (diuretic) • Hyperventilate (decrease CO2 levels) • No feeding due to glucose metabolism risk • “New” practices continue to be developed

  3. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia’s impact on nutrition • My patient vs. current research • Nutritional assessment based on findings

  4. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia’s impact on nutrition • My patient vs. current research • Nutritional assessment based on findings

  5. Patient Selection • Learning about a new protocol • “Cutting edge” research • Opportunity to directly measure resting metabolic rate

  6. Medical Diagnosis • Primary diagnosis: subarachnoid hemorrhage • Patient’s prognosis: poor • Hypothermia could improve outcomes?

  7. Therapeutic Hypothermia • Cooling: obtained goal temperature in 7 hours • Method of Cooling: • External Cooling Gaymar Meditherm • Cooled to: 32.8◦C • Duration: 5 days hypothermic • Re-warming: 0.1◦Cper hour to 37.1◦C • Obtained in 25 hours

  8. Medication/Paralytics • Paralytic • Vecuronium: 0.8 mg/kg/min • Sedatives • Midazolam: 0.7 mg/kg/hr • Fentanyl: 175 mg/hr • 3% saline @ 15 mL/hr • Insulin drip: 3 units/hr • KCl: 20mEq as needed

  9. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  10. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  11. Pathophysiology • Causes of neurological damage due to stroke or brain injuries • Mitochondrial damage • Production of free radicals • Reperfusion causing further damage

  12. Why hypothermia may work… • Hypothermia counteracts multiple steps of cellular injury following acute stroke • Reduces oxygen consumption • Inhibit free radical formation and inflammatory responses • Limit edema • Lower the amount of intracellular calcium • Exact mode is still being researched

  13. Benefits from metabolic effects • Neuroprotective effects by reduction or delay in metabolic consumption during the stress of a CNS injury • Reduces CMRO2 by 5% per degree Celsius • 5.9% reduction in energy • Slows lactic acid production to prevent acidosis • Lowers metabolic and energy demands • Promotes tissue preservation

  14. Methods for Cooling: Surface • Cold air, water and/or ice through a thermoconductive blanket • Cooling jackets • Ice packing • Advantages • Noninvasive • Inexpensive • Easy to implement • Disadvantages • Fluctuations in body temperature • Prolonged time to achieve the temperature goal

  15. Methods for Cooling: Intravascular • Infusion of ice-cold fluids through intravascular catheters (with metal or circulating cold water–filled balloon conductors) • Advantages • Shorter time to goal temperature • More precise hypothermic control • Less shivering • Disadvantages • More invasive • Higher cost

  16. Potential Complications • Shivering • Pneumonia • Decreased cardiac output • Hyperglycemia • Thrombocytopenia • Hypokalemia • Loss of gut function • Fever

  17. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  18. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  19. Energy expenditure in ischemic stroke patients treated with moderate hypothermia • 10 patients treated with moderate hypothermia (33∘C) following an acute ischemic stroke • Indirect calorimetry was performed over the first 6 days after admission • Mean daily TEE decreased significantly: • 1,549 kcals before initiation of hypothermia • 1,099 kcals the first day • 1,129 kcals the second day • 1,157 kcals the third day • Returned to baseline (and 16% above) after hypothermia was terminated

  20. Modification of the Harris-Benedict Equation to Predict the Energy Requirements of Critically Ill Patients during Mild Therapeutic Hypothermia • 5 patients suffering from acute cerebral injuries who underwent mild hypothermia • Indirect calorimetry measurements: • Every 3-4 hours during cooling/re-warming • Every 12 hours during the steady hypothermic state • Basal metabolic rate decreased by 30.3% • Every drop in temperature by one degree led to a 5.9% reduction in energy • Measured TEE was 16.7% lower than calculated TEE

  21. Metabolic Downregulation: A Key to Successful Neuroprotection? • Hypothermia slows but does not completely prevent the eventual depletion of ATP • Several studies suggest that metabolism is not significantly remarkable in neuroprotection • Example: rodents subjected to 20 minutes of forebrain ischemia • Brain levels of various metabolites were no different from rats who were in a normothermic state • Thus, the influence of hypothermia on cerebral metabolism probably does not fully explain its protective effect

  22. My patient vs. Current Research

  23. Equation vs. Calorimeter • Hypothermic State (32.8◦C) • 58% above the PSU equation calculation • Day 1 Re-warming (35.4◦C) • 51% above the PSU equation calculation • Day 2 Rewarming (37.1◦C) • 47% above the PSU equation calculation

  24. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  25. Overview • Patient information • Therapeutic Hypothermia • Therapeutic hypothermia impacts on nutrition • My patient vs. current research • Nutritional assessment based on findings

  26. NCP: Assessment • Calories • Prior to hypothermia protocol: • 2,475 kcals/day (PSU equation x 1.1) • During hypothermia protocol and medical paralysis: • 1,375 kcals/day (PSU equation) • After completion of hypothermia protocol: • 2,440 kcals/day (indirect calorimetry measurement) • Protein: 130 g/day (1.75 g/kg of adjusted body weight)

  27. Alterations during admission • Prior to hypothermia protocol • Nutren 1.5 @ 80 mL/hr (x 21 hours) • Beneprotein: 3 scoops/L of feeding • Nutrisource Fiber: 2 scoops in 50 mL of water 4x/day • During hypothermia protocol and medical paralysis • Replete @ 70 mL/hr (x 19.5 hours) • Beneprotein: 5 scoops/L of feeding • Nutrisource Fiber: 3 scoops in 75 mL of water 4x/day • After completion of hypothermia protocol • Nutren 1.5 @ 85 mL/hr (x 19.5 hours) • Beneprotein: 3 scoops/L of feeding • Nutrisource Fiber: 3 scoops in 75 mL of water 4x/day

  28. NCP: Diagnosis • Increased nutrient needs (energy) (NI- 5.1) related to therapeutic hypothermia protocol as evidenced by resting metabolic rate calorimetry measurement of 1,950 calories while in a hypothermic state.

  29. NCP: Intervention • Food and or/nutrient delivery (ND) • Enteral and Parenteral Nutrition (ND-2) – Enteral Nutrition (ND-2.1) – Composition: • Provided nutrition through the GI tract via keofeed tube based on patient’s calculated protein and measured energy needs.

  30. NCP: Monitoring and Evaluation Indicator: Enteral nutrition intake (FH-1.3.1) – Formula/solution Criteria: Patient will receive Nutren 1.5 @ 80 mL/hr, Beneprotein 3 scoops/L of feeding, and Nutrisource Fiber 2 scoops in 50 mL of water 4x/day in order to meet her calculated protein and energy requirements.

  31. Indicator: Enteral nutrition intake (FH-1.3.1) – Formula/solution Criteria: Patient will receive Replete @ 70 mL/hr, Beneprotein 5 scoops/L of feeding, and Nutrisource Fiber 3 scoops in 75 mL of water 4x/day in order to meet her energy requirements during the hypothermia protocol. Indicator: Enteral nutrition intake (FH-1.3.1) – Formula/solution Criteria: Patient will receive Nutren 1.5 @ 85 mL/hr, Beneprotein 3 scoops/L of feeding, and Nutrisource Fiber 3 scoops in 75 mL of water four times per day in order to meet her energy requirements after the hypothermia protocol is complete.

  32. Conclusion • Limited research • Measurement of my patient prior to hypothermia protocol may have given a different result • Case-to-case basis • Establish measurement in protocol • Therapeutic hypothermia may have benefits, but not necessarily nutritionally

  33. Badjatia, Neeraj, and Evangelia Strongilis. "Metabolic Impact of Shivering During Therapeutic Temperature Modulation." Stroke. American Stroke Association, 16 Oct. 2008. Web. 30 Apr. 2015. • Bardutzky, Juergen, Dimitrios Georgiadis, Rainer Kollmar, and Stefan Schwab. "Energy Expenditure in Ischemic Stroke Patients Treated with Moderate Hypothermia." Intensive Care Medicine 30.1 (2004): 151-54. Web. 21 Apr. 2015. • C., Tommasino. "Fluids and the Neurosurgical Patient." Anesthesiology Clinics of North America (2002): n. pag. WBS. Standford University, 2002. Web. 22 Apr. 2015. • "Diabetes, Endocrine | Insulin Drips." Uwhealth.org. UW Health, 2013. Web. 23 Apr. 2015. • "Fentanyl: Indications, Side Effects, Warnings - Drugs.com." Vecuronium: Indications, Side Effects, Warnings - Drugs.com. Drugs.com. Know More. Be Sure., 2012. Web. 30 Apr. 2015. • Groysman, Leonid. "Therapeutic Hypothermia in Acute Ischemic Stroke." Medscape. Neurosurg Focus, 2011. Web. 20 Apr. 2015. • Hartl, Roger. "Effect of Early Nutrition on Deaths Due to Severe Traumatic Brain Injury." Journal of Neurosurg (2008): n. pag. J Neurosurg. Web. 28 Apr. 2015. • Hemmen, Thomas M., and Patrick D. Lyden. "New Approaches to Clinical Trials in Neuroprotection: Introductino." Stroke. American Stroke Association, 2007. Web. 30 Apr. 2015. • Liu, Liping, and Midori A. Yenari. "Clinical Application of Therapeutic Hypothermia in Stroke." Neurological Research. U.S. National Library of Medicine, May 2009. Web. 29 Apr. 2015. • "Midazolam: Indications, Side Effects, Warnings - Drugs.com." Vecuronium: Indications, Side Effects, Warnings - Drugs.com. Drugs.com. Know More. Be Sure., 2014. Web. 30 Apr. 2015. • "Neuroscience Therapeutic Temperature Modulation Guideline (TTM)." Penn State Hershey Medical Center. • Portoroz, Slovenia. "Update on Therapeutic Temperature Management."Critical Care 6.2 (2012): 1-42. Meeting Abstracts. 2012 June 7. Web. 22 Apr. 2015.  • Saur, Joachim, Hans Leweling, and Frederik Trinkmann. "Modification of the Harris-Benedict Equation to Predict the Energy Requirements of Critically Ill Patients during Mild Therapeutic Hypothermia." In Vivo 22 (2008): 143-46. First Department of Medicine, 2008. Web. 20 Apr. 2015. • Vecuronium: Indications, Side Effects, Warnings - Drugs.com." Vecuronium: Indications, Side Effects, Warnings - Drugs.com. Drugs.com. Know More. Be Sure., 2014. Web. 30 Apr. 2015.  • Worp, H. Bart Van Der, Malcolm R. Macleod, and Rainer Kollmar. "Therapeutic Hypothermia for Acute Ischemic Stroke: Ready to Start Large Randomized Trials?" Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. Nature Publishing Group, 2008. Web. 28 Apr. 2015. • Yenari, Midori A., and Thomas M. Hemmen. "Neuroprotection." Stroke. American Stroke Association, 2010. Web. 20 Apr. 2015.  • Yenari, Midori, and Kazuo Kitagawa. "Metabolic Downregulation." Stroke. American Stroke Association, 2008. Web. 29 Apr. 2015. • Ziai, Wendy C., and Marek A. Mirski. "Use of Hypertonic Saline in Ischemic Stroke." Stroke. American Stroke Association, 2002. Web. 23 Apr. 2015.

More Related